000274047 001__ 274047
000274047 005__ 20250115165651.0
000274047 0247_ $$2doi$$a10.1016/j.clbc.2024.06.011
000274047 0247_ $$2pmid$$apmid:39153934
000274047 0247_ $$2ISSN$$a1526-8209
000274047 0247_ $$2ISSN$$a1938-0666
000274047 037__ $$aDZNE-2025-00028
000274047 041__ $$aEnglish
000274047 082__ $$a610
000274047 1001_ $$aSchulze, Jan Ben$$b0
000274047 245__ $$aPsychiatric Diagnoses and Their Treatment in Women With Breast Cancer: A Latent Class Analysis of 1062 Inpatients.
000274047 260__ $$aDallas, Tex.$$bCancer Information Group$$c2025
000274047 3367_ $$2DRIVER$$aarticle
000274047 3367_ $$2DataCite$$aOutput Types/Journal article
000274047 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1736940296_13620
000274047 3367_ $$2BibTeX$$aARTICLE
000274047 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000274047 3367_ $$00$$2EndNote$$aJournal Article
000274047 520__ $$aPsycho-oncological support (POS) and psychopharmacological interventions are effective in treating psychiatric symptoms in patients with breast cancer. However, despite high prevalences of psychiatric disorders in patients with breast cancer, a significant proportion remains untreated.Data from 1062 breast cancer patients who had been diagnosed and treated at a Comprehensive Cancer Center between 2012 and 2019 were analyzed retrospectively. We descriptively evaluated the number of patients with a psychiatric diagnosis, POS and psychiatric medication. Latent class analysis was used to examine the relationship between ICD-10 coded psychiatric diagnoses, POS, psychiatric medication, and, as important prognostic factors, tumor stage and somatic comorbidity.31.5% of all patients had a psychiatric diagnosis, 20% received POS and up to 60% received psychiatric medication. Latent class analysis revealed three subgroups: 1) patients with a low cancer stage, low somatic comorbidity, no psychiatric diagnosis, no POS and no psychiatric medication; 2) patients with a low cancer stage, low somatic comorbidity, a psychiatric diagnosis, and a higher probability of POS and psychiatric medication than class 1 and class 3; 3) patients with advanced cancer stage, high somatic comorbidity, a higher probability of a psychiatric diagnosis and POS than class 1, and no psychiatric medication.This study indicated a high prevalence of psychiatric disorders among patients with breast cancer and a discrepancy between the number of patients having a psychiatric disorder and those receiving psychiatric medication. The identification of subgroups might contribute to better tailored treatment for those patients whose needs are insufficiently met.
000274047 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000274047 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000274047 650_7 $$2Other$$aBreast cancer
000274047 650_7 $$2Other$$aPsychiatric comorbidity
000274047 650_7 $$2Other$$aPsychiatric medication
000274047 650_7 $$2Other$$aPsychiatric treatment
000274047 650_7 $$2Other$$aPsycho-oncology
000274047 650_7 $$2NLM Chemicals$$aPsychotropic Drugs
000274047 650_2 $$2MeSH$$aHumans
000274047 650_2 $$2MeSH$$aFemale
000274047 650_2 $$2MeSH$$aBreast Neoplasms: psychology
000274047 650_2 $$2MeSH$$aBreast Neoplasms: therapy
000274047 650_2 $$2MeSH$$aBreast Neoplasms: pathology
000274047 650_2 $$2MeSH$$aMental Disorders: epidemiology
000274047 650_2 $$2MeSH$$aMiddle Aged
000274047 650_2 $$2MeSH$$aRetrospective Studies
000274047 650_2 $$2MeSH$$aAdult
000274047 650_2 $$2MeSH$$aLatent Class Analysis
000274047 650_2 $$2MeSH$$aAged
000274047 650_2 $$2MeSH$$aComorbidity
000274047 650_2 $$2MeSH$$aPrevalence
000274047 650_2 $$2MeSH$$aInpatients: psychology
000274047 650_2 $$2MeSH$$aInpatients: statistics & numerical data
000274047 650_2 $$2MeSH$$aPrognosis
000274047 650_2 $$2MeSH$$aPsychotropic Drugs: therapeutic use
000274047 7001_ $$0P:(DE-2719)9002951$$aDörner, Marc$$b1$$udzne
000274047 7001_ $$aHuber, Mona$$b2
000274047 7001_ $$aJordan, Katja-Daniela$$b3
000274047 7001_ $$aKänel, Roland von$$b4
000274047 7001_ $$aEuler, Sebastian$$b5
000274047 773__ $$0PERI:(DE-600)2175989-3$$a10.1016/j.clbc.2024.06.011$$gVol. 25, no. 1, p. e22 - e29$$n1$$pe22 - e29$$tClinical breast cancer$$v25$$x1526-8209$$y2025
000274047 8564_ $$uhttps://pub.dzne.de/record/274047/files/DZNE-2025-00028.pdf$$yOpenAccess
000274047 8564_ $$uhttps://pub.dzne.de/record/274047/files/DZNE-2025-00028.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000274047 909CO $$ooai:pub.dzne.de:274047$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000274047 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002951$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000274047 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000274047 9141_ $$y2025
000274047 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-19
000274047 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000274047 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN BREAST CANCER : 2022$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000274047 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-19
000274047 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000274047 9201_ $$0I:(DE-2719)1310010$$kAG Schreiber$$lMixed Cerebral Pathologies and Cognitive Aging$$x0
000274047 980__ $$ajournal
000274047 980__ $$aVDB
000274047 980__ $$aUNRESTRICTED
000274047 980__ $$aI:(DE-2719)1310010
000274047 9801_ $$aFullTexts